We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Rheumatology

Journal Scan / Research · January 19, 2022

Efficacy and Safety of Belimumab in Black Patients With SLE

Arthritis & Rheumatology (Hoboken, N.J.)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Arthritis & Rheumatology (Hoboken, N.J.)
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus
Arthritis Rheumatol 2022 Jan 01;74(1)112-123, E Ginzler, LS Guedes Barbosa, D D'Cruz, R Furie, K Maksimowicz-McKinnon, J Oates, MB Santiago, A Saxena, S Sheikh, DL Bass, SW Burriss, JA Gilbride, JG Groark, M Miller, A Pierce, DA Roth, B Ji

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading